4
Changes in Ownership
BioXcel Therapeutics, Inc. Filed Acc 0001104659-24-044862
See Remarks sold 165 shares at $2.62 ($432)
- See Remarks acquired 2,771 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| O'Neill Vincent See Remarks | 2024-03-14 | Option exercise 10b5-1 | +521 | 3,323 | D | ||
| O'Neill Vincent See Remarks | 2024-03-15 | Option exercise 10b5-1 | +2,250 | 5,573 | D | ||
| O'Neill Vincent See Remarks | 2024-04-04 | Sale 10b5-1 | −165 | $2.62 | $432 | 5,408 | D |
| Derivatives | |||||||
| O'Neill Vincent See Remarks | 2024-03-14 | Option exercise · Restricted Stock Units 10b5-1 | −521 | 4,169 | D | ||
| O'Neill Vincent See Remarks | 2024-03-15 | Option exercise · Restricted Stock Units 10b5-1 | −2,250 | 6,750 | D | ||
| Open-market sales · 165 sh · avg $2.62 · $432 | |||||||
Loading xslF345X05/tm2411220-6_4seq1.xml…